![](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/0dd95a2aa9ba2441e78dd4d2ccdd7e6b852d5736-480x209.jpg?fit=crop&auto=format)
ODAC Votes in Favor of New Perioperative NSCLC Trial Design Proposals
The FDA’s Oncologic Advisory Drug Committee (ODAC) cast a 11-to-0 vote in favor of the agency mandating that new clinical trial design proposals should include sufficient within-trial assessments of the contribution of treatment phase in studies evaluating …